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Despite a profusion of published reports, it is sur-
prisingly difficult to identify series in which the cause
of stroke is systematically documented after carotid
endarterectomy (CEA). Before 1992, the 30-day risk
of stroke/death in our unit was 6% (4% intraopera-
tive, 2% postoperative), which is within national and
international guidelines. However, we were motivat-
ed to see whether this could be improved. A prospec-
tive audit was therefore started in 1992 to determine
if the introduction of a policy of monitoring and
quality control (QC) assessment was associated with
a sustained reduction in the operative risk.
The research program now comprises several
phases, each characterized by a single change in pro-
tocol followed by a further prospective audit; it
includes more than 800 patients. The first study
demonstrated that although transcranial Doppler
ultrasound (TCD) scanning and completion angios-
copy virtually abolished intraoperative stroke, they
had little effect on the 3% rate of postoperative throm-
botic stroke.1,2 On review, each thrombosis was
found to have occurred within 6 hours of surgery and
to involve a white, platelet thrombus adherent to the
endarterectomy zone, with no evidence of underlying
technical error. The second study showed, however,
that postoperative thrombotic stroke was preceded by
a 1- to 2-hour phase of increasing embolization; this
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highlighted the potential for prophylactic surgical or
therapeutic intervention.3,4 Thereafter, dextran 40
(Pharmacia Ltd, Milton Keynes, United Kingdom)
was administered to all patients after restoration of
flow. Although no thromboses were encountered, the
incidence of neck hematoma increased, and one
patient died through multiorgan failure that was
attributed to dextran use.5 Within weeks of the aban-
donment of routine dextran therapy, an additional
thrombotic stroke occurred. The fourth phase of the
program established that 50% of patients had one or
more emboli detected postoperatively but that only
5% developed the pattern of sustained embolization
that had previously been shown to be highly predic-
tive of progression to thrombosis. In each case,
embolization ceased after selective dextran therapy,
and no patient had a thrombotic stroke.5,6
Since the final protocol change in October 1995,
a total of 500 consecutive patients have undergone
CEA according to the full monitoring protocol,
which comprises intraoperative TCD, angioscopy,
and 3 hours of postoperative TCD monitoring, dex-
tran 40 being administered only to patients with high
rates of embolization. This article documents the
influence of TCD and angioscopy on surgical deci-
sion making (particularly regarding the prevention of
technical error), the incidence and effect of dextran
on rates of embolization after CEA, and the impact
of the overall monitoring program on outcome.
MATERIALS AND METHODS
Between October 1, 1995, and January 23,
1999, a total of 500 consecutive patients were
entered into a prospective audit of outcome after
CEA. Permission for this study was granted by the
Leicestershire Area Ethics Committee.
Fig 1. Top left, Hysteroscope used during intraoperative angioscopy. Top right, Completion angioscopy
study of endarterectomy zone and distal ICA shows possible plane of dissection under intima; this was
corrected surgically. Bottom left, Mural thrombus adherent to endarterectomy zone, adjacent to prox-
imal common carotid step. Bottom right, Thrombotic material retrieved from endarterectomy zone
after angioscopy.
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Preoperative assessment. Patients were assessed
in a “single visit” clinic during which risk factor man-
agement and assessment by duplex scanning were
performed. Angiography was undertaken in fewer
than 5% of cases.7 Aspirin therapy (75-150 mg daily)
was continued throughout the operative period.
Duplex scanning was repeated within 24 hours of
surgery, and all patients had their TCD windows
marked. Of the 500 patients, 275 (55%) presented
with transient ischemic attack/amaurosis fugax and
146 (29%) with stroke; 79 patients (16%) were
asymptomatic. Seventy asymptomatic patients (88%)
had bilateral severe disease or severe stenosis and
contralateral occlusion. One hundred twenty-three
patients (25%) had histories of myocardial infarction,
and 158 patients (32%) were on antiangina therapy.
A total of 310 patients (62%) were receiving treat-
ment for hypertension, and 74 (15%) were diabetic.
A unilateral stenosis ≥ 70% was present in each of
317 patients (63%), 95 patients (19%) had bilateral
stenoses ≥ 70%, and each of 88 patients (18%) had a
stenosis ≥ 70% and contralateral occlusion.
Operative technique. The basic technique of
CEA—general anesthesia, systemic heparinization,
loupe magnification, routine shunting (Pruitt-Inahara;
Cryolife Co, St Petersburg, Fla), patching (collagen-
impregnated Dacron [DuPont, Wilmington, Del] [n
= 361] or groin saphenous vein [n = 115]), and distal
intimal tacking—has remained unchanged since 1988.
The current series of 500 CEAs comprises CEA (n =
476) and carotid venous bypass grafting (n = 24). A
total of 243 procedures were performed by consul-
tants (A. R. N., N. J. M. L., M. M. T., P. R. F. B.) and
257 by a vascular higher surgical trainee (H. S. T.)
under supervision.
Intraoperative monitoring. TCD monitoring
was begun after induction of anesthesia through use
of a fixed 2-MHz head probe (Scimed PC2-64B,
Fishponds, Bristol, United Kingdom) that was pro-
tected by a semicircular flat-plate head guard. The
surgeon and anesthetist aimed to ensure that mean
blood flow velocity in the middle cerebral artery
(MCAV) was more than 15 cm/s at all times. The
threshold of 15 cm/s was chosen because Halsey et
al8 have shown this to correlate with loss of cerebral
electrical activity. If the MCAV was less than 15
cm/s after shunt insertion, the shunt was reposi-
tioned to exclude abutment against the lumen of the
distal internal carotid artery (ICA). If the MCAV
was still less than 15 cm/s, the blood pressure was
therapeutically elevated by the anesthetist. Any occa-
sion on which TCD significantly altered operative
decision making was recorded. All MCAV data were
recorded onto digital audio tape for offline analysis.
Before complete patch closure, a 5-mm space was
retained adjacent to the orifice of the external
carotid artery. The shunt was removed and all vessels
were back vented and irrigated with heparinized
saline solution. The lumen of the endarterectomy
zone was then inspected by means of a flexible hys-
teroscope (Olympus 1070-48, Olympus America,
Melville, NY; Fig 1, top left).
Our policy for revision after angioscopy has
remained unchanged since the pilot study; it calls for
the repair of all intimal flaps larger than 3 mm and the
removal of any residual thrombi from the lumen.1
Postoperative monitoring. After recovery
from anesthesia, the patient was transferred to the
recovery area of the operating theater or to the
high dependency unit for a 3-hour period of TCD
monitoring. All TCD data were recorded onto
digital audio tape for offline analysis. Previous
work in this department has demonstrated that
emboli detected in the postoperative period are
exclusively particulate9 and that 3 hours of moni-
toring is as effective as 6 hours.6 Dextran 40 was
administered to any patient who had (1) 25 or
more emboli in any 10-minute period or (2)
emboli that distorted the MCA waveform, sug-
gesting that they were large. The threshold of 25
Table I. Incidence of embolization in early postop-
erative period after CEA
No. of emboli detected in 3 h No. of patients (%)
0 187 (41.5)
1-20 195 (43.2)
21-50 37 (8.2)
51-100 16 (3.5)
101-200 6 (1.3)
201-300 4 (1.0)
300+ 6 (1.3)
Table II. Effect of dextran on median embolus
count
Hour* Median embolus count 95% CI
First 108 59-140
Second 82 35-98
Third 33 14-53
Fourth 16 1-25
Fifth 6 0-13
Sixth 0 0
*After onset of dextran therapy.
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or more emboli per 10-minute period was based
on the findings of the original pilot study.1
Intravenous dextran was administered as a 20-mL
bolus and then at a rate of 20 mL/h, increased
stepwise every 10 minutes to a maximum of 40
mL/h if there was no reduction in the rate of
embolization. Once the rate of embolization was
stabilized or reduced, dextran was continued at
that dose for a further 12 hours.
Postoperative assessment. Any new neurologic
deficit persisting for more than 24 hours within the
first 30 days after surgery was classified as a stroke,
and its severity was scored at 30 days by a neurolo-
gist using the Oxfordshire Handicap Scale (OHS).10
The OHS scale is a modified version of the Rankin
Score and takes into account the disability associat-
ed with dysphasia/aphasia. A stroke score of 0 to 2
was classified as nondisabling; a score of 3 to 5 was
deemed disabling. Any patient who had a periopera-
tive stroke was investigated through use of comput-
ed tomography (CT) head scanning, duplex ultra-
sound scanning, and TCD examination of the
extracranial and intracranial circulation. Patients
who had fatal strokes underwent autopsy. As part of
an internal quality audit, each of the last 223 CEAs
in this series was evaluated in the early postoperative
period by a neurologist (H. A.).
RESULTS
Intraoperative TCD
Intraoperative TCD monitoring was achieved in
451 patients (90%). Thirty-seven patients (7%) had
no cranial window; four patients (1%) were not
monitored, because two CEAs were performed
simultaneously in adjacent operating theaters and
there was insufficient equipment/staff. In eight
patients (2%), there was technical equipment failure
or the wrong artery was insonated (most common-
ly, the posterior cerebral artery).
It was difficult to objectively audit occasions
when TCD altered operative/anesthetic practice.
Surgeons adjusted their technique if there was spon-
taneous embolization during dissection, and the
outcome of this was impossible to audit reliably.
Similarly, transient shunt kinking was immediately
recognized and corrected. However, TCD was of
particular benefit in eight patients (1.8%). TCD
diagnosed one on-table cardiac arrest after electro-
mechanical dissociation (normal electrocardiogram,
zero MCAV), and it guided management during
one case of anaphylactic shock when the systolic
blood pressure was only 26 mm Hg. In two patients,
the external carotid artery was preferentially shunt-
ed because MCAV was less than 10 cm/s when the
shunt was inserted into the ICA. In three other
patients, MCAV was less than 10 cm/s after shunt
insertion; in each of these cases, repositioning of the
distal shunt limb or partial deflation of the distal
shunt balloon increased MCAV to more than 20
cm/s. We assume that in these situations the distal
shunt lumen impinged on the distal ICA wall.
Finally, TCD diagnosed one case of on-table throm-
bosis as the neck was being closed.
Completion angioscopy
Nineteen patients (4%) did not undergo
angioscopy, either because of equipment failure or
because a reversed saphenous vein bypass had been
performed. After a minor protocol change during
the study, all bypass graft patients now undergo
angioscopy. Of the 481 patients undergoing
angioscopy, 445 (93%) underwent a normal study
(Fig 2); 21 (4%) had fragments of luminal thrombus
removed (Fig 1, bottom left and right), the source of
the thrombus being bleeding from the vasa vasorum
onto the highly thrombogenic endarterectomy sur-
face (Fig 3). The thrombus was removed by suction
aspiration and repeated irrigation with heparinized
saline solution before repeat angioscopy. The distal
anastomosis was revised in only 15 patients (3%) to
Fig 2. Normal completion angioscopy.
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correct either a distal intimal flap or an elevated dis-
tal intimal step (Fig 1, top right). The median time
taken to perform angioscopy, specifically audited in
the last 80 CEAs in this series, was 51 seconds (95%
CI, 35-67 seconds).
Postoperative TCD monitoring
Each of 451 patients (91%) underwent 3 hours
of TCD monitoring postoperatively (Table I). In all,
313 patients (69.4%) had one or more emboli
detected within 3 hours of surgery, but 93% had
fewer than 50 emboli detected in total. Of those
destined to embolize, 179 (57%) started to
embolize in the first hour, 122 (39%) in the second
hour, and 12 (4%) in the third hour. Twenty-two
patients (4.9%) had more than 25 emboli per 10-
minute period (n = 19) or large emboli that distort-
ed the MCA waveform (n = 3); they received adju-
vant dextran. After dextran therapy, the median
embolus count fell rapidly (Table II). However, the
dose of dextran had to be increased in seven (32%)
of 22 patients to control the rate of embolization.
All patients destined to receive dextran had started
to embolize within the first 2 postoperative hours.
No carotid thrombosis and no embolic stroke
occurred in any of the 287 patients with no emboli
detected in the postoperative period. In addition, no
carotid thrombosis occurred in any of the patients
receiving dextran. However, each of two patients
receiving dextran had a focal embolic stroke in the
postoperative period.
Thirty-day complications
Intraoperative stroke. Having undergone a vein
bypass graft to the skull base, one patient (0.2%)
recovered from anesthesia with a nondisabling stroke
(case 9, Table III). He had zero MCAV during
clamping, indicating negligible collateral flow via the
circle of Willis. Profuse embolization started within
minutes of flow restoration. MCAV fell rapidly to 3
cm/s, and a diagnosis of on-table thrombosis was
made. Angiography revealed thrombus in the mid-
section of the graft, and this was removed (there was
no evidence of underlying technical error). Despite
intravenous heparin and dextran, the graft reocclud-
ed within minutes of flow restoration (thrombus in
Fig 3. Bleeding vasa vasorum (arrow) that is source of luminal thrombus in endarterectomy zone.
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the distal graft), and a patch was placed across the
distal anastomosis. Despite two episodes of on-table
thrombosis and more than 750 emboli, the patient
recovered from anesthesia with a dysphasic stroke but
no motor/sensory deficit (OHS 2 at 30 days). In the
absence of TCD, the neurologic deficit would have
become apparent only when attempts were made to
awaken the patient, and the outcome would almost
certainly have been far worse because of his negligi-
ble collateral circulation.
Postoperative complications. Having made an
uneventful recovery from anesthesia, 10 patients
(2%) either died (n = 6) or had a nonfatal stroke (n =
4) within 30 days of surgery (Table III). None of the
deaths followed thromboembolic events in the
carotid territory. The most common causes of death
were intracranial hemorrhage (ICH; n = 2) and car-
diac pathology (n = 3), but none of these patients
had received adjuvant dextran therapy. Of the four
postoperative nonfatal strokes, two were disabling
and two were nondisabling (Table III). One dis-
abling stroke (case 8, Table III) followed a CT-
proven ICH on day 23 (no dextran given). Each of
three other patients had a CT documented carotid
territory embolic stroke. The first of these (case 7,
Table III) developed profound cardiac failure after
recovery and required immediate reintubation and
inotropic support. Within 1 hour there was evidence
of sustained embolization, but only a small dose of
dextran was administered because of the cardiac fail-
ure. Accordingly, the rate of embolization was
uncontrolled, and a hemiparetic stroke was apparent
on extubation (OHS score 3 on day 30). The second
of these patients was discharged home on day 3 (case
11, Table III) but readmitted with a minor stroke on
day 9. Duplex scanning and TCD were normal, and
there was no evidence of ongoing embolization;
however, serial electrocardiograms and cardiac
enzymes indicated that she had recently had a
myocardial infarction. A CT scan confirmed a focal
infarct, and it might be that this was cardioembolic
in origin. The third embolic stroke (case 10, Table
III) occurred in a 72-year-old man who had received
dextran in the early postoperative period. Embol-
ization was rapidly controlled with dextran (Fig 4,
A), and no emboli were evident when TCD was
repeated 24 hours postoperatively. On the fifth day,
the patient had an upper limb monoparesis, and
again TCD revealed profuse embolization. In view of
the inevitable neck edema and the fact that the initial
endarterectomy had extended high, he was treated
with high-dose dextran (50 mL/h); this immediate-
ly controlled the embolization (Fig 4, B). The
patient made a rapid recovery thereafter and was dis-
charged home on day 9 (OHS score 1 on day 30).
Table IV summarizes the results from our series
of 500 patients relative to presentation, degree of
stenosis, the grade of the operating surgeon, whether
the assessor was a neurologist or surgeon, and
patient age and sex. The only significant difference
between any of the groups was in age; patients older
than 75 years were significantly more likely than
younger patients to die or have disabling strokes
(5/115 vs 3/385, P = .03, Fisher exact test). No
other factor was identified as a significant risk factor
for death or stroke. Overall, the death and/or dis-
abling stroke rate in this study was 1.6%. The death
and/or any stroke rate was 2.2% despite the fact that
more than 50% of the CEAs were performed by
trainees under supervision. The incidence of ipsilat-
Table III. Etiology and timing of perioperative complications
Death Disabling CVA Nondisabling CVA
Case no. Etiology Timing Etiology Timing Etiology Timing
1 ICH Day 3 — — — —
2 MI Day 3 — — — —
3 Cardiac failure Day 5 — — — —
4 Brainstem CVA Day 7 — — — —
5 ICH Day 7 — — — —
6 Cardiac failure Day 14 — — — —
7 — — MCA embolism < 6 h* — —
8 — — ICH Day 23 — —
9 — — — — ICA thrombosis On table
10 — — — — MCA embolism Day 5
11 — — — — Cardiac embolism Day 9
*It is assumed that this stroke occurred during phase of sustained embolization while patient was reintubated and treated for severe car-
diac failure. For this reason, therapeutic doses of dextran could not be administered.
ICH, Intracranial hemorrhage; MI, myocardial infarction; CVA, cerebrovascular accident.
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eral carotid territory thromboembolic stroke was
0.8% (on-table carotid thrombosis, n = 1; postoper-
ative embolic stroke, n = 3). If the potential cardiac
embolic stroke is excluded, the rate of ipsilateral
carotid territory embolic stroke was only 0.6%.
DISCUSSION
Before 1992, the 30-day risk of death/stroke
after CEA in our unit was 6%, most of the strokes
being apparent on recovery from anesthesia.
Although this rate is within international guidelines,
we were motivated to see if it could be reduced.
Such was the impetus underlying the current
research program. The operative technique (routine
shunting, patching, tacking) has remained constant
since 1988, and we are not aware of any scientific
evidence that indicates a need to change this prac-
tice. Indeed, the role of the shunt and carotid patch
has so dominated debate that, for some practition-
ers, it has assumed the convenient role of scapegoat;
should problems arise, the surgeon is thereby
absolved of responsibility.11
We chose to evaluate the role of monitoring,
partly because there was evidence that implementa-
tion of such a protocol might improve outcome.12,13
Our hypothesis was that implementation of a moni-
toring program should reduce the operative risk by
preventing technical error, and it was based on the
following observations: first, intraoperative stroke is
always attributable to a specific event; second, most
strokes follow technical error14 to which high-risk
patients have little or no cerebral vascular reserve.15
Planning the study, we were aware that previous
attempts to determine whether monitoring positively
influenced outcome were largely unsuccessful.
However, in retrospect, this probably reflected a fail-
ure to ask the right questions.11 First, most of the ear-
lier investigations were designed to identify clamp
ischemia so as to develop criteria for shunting, even
though hemodynamic failure is a relatively rare cause
of stroke.16,17 Few criteria have been developed to
prevent thromboembolism. Second, there remains the
flawed assumption that a single monitoring modality is
superior to all others. Third, despite awareness that
technical error is the factor that most frequently
underlies operative stroke, few surgeons include any
form of QC assessment in their monitoring protocol.
Thus, is it reasonable to blame electroencephalogra-
phy, somatosensory evoked potential, TCD, or awake
testing for failing to prevent a stroke due to emboliza-
tion of luminal thrombus if no effort was made to
remove this before restoration of flow? The rationale
underlying monitoring and QC assessment is simple:
the prevention of operative stroke is preferable to its
treatment (ie, once a stroke has occurred, there may be
little that one can do to prevent its consequences).
Advantages of the latest study include its
prospective design and large numbers, use of a stan-
dardized operative technique throughout, use of
independent neurologic assessment, and the fact
that the investigation was preceded by discrete phas-
es wherein a single change was made to the proto-
col, after which there was a further period of audit.
To date, it is the largest series reporting the roles of
TCD and angioscopy and the natural history of
postoperative embolization and progression to
carotid thrombosis. It has also highlighted the
importance of awareness of the fact that intraopera-
tive stroke and postoperative stroke have different
Fig 4. A, Effect of dextran on embolus count in early
postoperative period in patient who had postoperative
embolic stroke on day 5 (case 10, Table III). Within 4
hours, embolization had ceased, and no neurologic deficit
occurred. B, On day 5, patient had upper limb mono-
paresis and was found to be embolizing profusely. Dextran
was again administered (50 mL/h), rate of embolization
decreased rapidly, and patient made significant clinical
recovery (OHS score of 1 at 30 days).
A
B
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causes, which is essential when a global monitoring
protocol is being designed.
In our original study, we observed that (for us)
the combination of TCD and angioscopy offered the
maximum yield in terms of identification of techni-
cal error.1 Before 1992, intraoperative stroke was
our principal problem. However, since the introduc-
tion of a policy of angioscopy and TCD, only two
(0.25%) of 800 CEAs have been complicated by
intraoperative stroke, and both of those followed
on-table thrombosis. Although this was a nonran-
domized observational study, the large numbers
involved suggest a positive causal relationship. The
choice of TCD and angioscopy reflects their com-
patible roles as monitoring and QC techniques. The
role of TCD is as follows: (1) to warn of particulate
embolization from unstable plaques during dissec-
tion, thereby enabling modification of the surgical
technique18; (2) to ensure that MCAV is always
more than 15 cm/s, thereby minimizing the risks of
hemodynamic injury, particularly in the ischemic
penumbra8; and (3) to ensure optimal shunt func-
tion. There would seem to be little point in using a
shunt if one does not also ensure that it is working.
This and other studies suggest that shunt malfunc-
tion occurs in 1% to 3% of CEAs19—a fact that may
have contributed to the misconception that shunts
cause as many strokes as they prevent. Finally, TCD
is currently the only method capable of diagnosing
on-table thrombosis, which was responsible for the
single intraoperative stroke seen in this series. In the
absence of TCD, the ensuing deficit would
undoubtedly have been far worse. Once the learning
curve has been mastered, TCD is unobtrusive; it can
be of considerable value in the training of junior col-
leagues in carotid surgery, and it contributes to a
reduction in the incidence of particulate emboliza-
tion during the procedure.18
The principle role of angioscopy is the identifi-
cation and removal of luminal thrombus before flow
restoration in 4% of patients. Some of these throm-
bi have been surprisingly large (Fig 1, bottom left)
and resistant to blind irrigation with heparinized
saline solution. There has been scepticism as to the
source of these thrombi, but this study has shown
that they originate from the vasa vasorum (Fig 3).
Although completion duplex scanning and angio-
graphic evaluation are alternatives to angioscopy,
they can be performed only after flow has been
restored, by which time any luminal thrombus may
already have embolized to the brain.
On a practical note, multifiber angioscopes are
too fragile; the flexible hysteroscope is preferable. It
usually requires insertion only into the endarterec-
tomy zone, inasmuch as the distal views are other-
wise quite excellent. In particular, there is no need
to advance the scope over the intimal steps, and no
patient in our overall experience of 800+ cases has
had an operative stroke as a result of a minute or two
of added clamp time.
Table IV. 30-day operative risk after CEA
Parameter No. of patients Death and/or disabling stroke (%) Death and/or any stroke (%)
Presentation
TIA/AFX 275 1.8 2.18
Stroke 146 2.05 2.73
Asymptomatic 79 0.0 0.0
Degree of stenosis
Unilateral 317 0.9 1.6
Bilateral 95 2.1 3.15
Contralateral occlusion 88 2.27 3.4
Operator
Consultant 243 1.65 2.5
Supervised HST 257 1.56 1.95
Patient assessor
Surgeon 277 1.44 2.17
Neurologist 223 1.80 2.24
Sex
Male 329 1.2 1.8
Female 171 2.3 2.9
Age (y)
< 75 385 0.8 1.6
≥ 75 115 4.3 4.3
Overall 500 1.6 2.2
TIA, Transient ischemic attack.
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Although we were pleased to observe that the risk
of intraoperative stroke was virtually abolished after
the introduction of TCD and angioscopy, we were
concerned to note that it had no impact on the risk of
postoperative thrombotic stroke. By 1995, this was
the single most common cause of morbidity and mor-
tality in our practice. In the past it had been assumed
that thrombosis invariably followed surgeon error,
but when our patients were reexplored, we consis-
tently found that each had a white friable platelet
thrombus adherent to the endarterectomy zone, with
no evidence of underlying technical error.20 Research
suggests that platelets adhere to the endarterectomy
zone within minutes of flow restoration.17 However,
evidence from three continents has now clearly shown
that postoperative carotid thrombosis is preceded by
a period of sustained or increasing emboliza-
tion.1,3,4,19,21-23 In particular, Levi et al21 demon-
strated that up to 60% of patients with sustained
embolization would progress to a stroke, and this is
in accord with our own experience.1 In this latest
series of 500 patients, 42% had no emboli detected in
the first three postoperative hours, and none had an
ipsilateral carotid territory stroke within 30 days.
Although 58% of patients had one or more emboli
detected, in 89% of these the early phase of emboliza-
tion was rapidly self-limiting, and the number of
emboli fell to zero without therapeutic intervention.
No patient had an ipsilateral embolic stroke. Only 22
patients (5%) had sustained rates of embolization
(more than 25 emboli in 10 minutes) and were con-
sidered on the basis of previous experience to have at
least a 50% risk of progressing to thrombotic
stroke.1,21 Each of these patients received dextran,
and embolization ceased in all but one, although the
dose had to be increased in 32%. No patient in this
series had a carotid thrombosis, and none had to be
reexplored. However, two patients receiving dextran
had focal embolic strokes. Finally, no patient destined
to have an ICH or major cardiac event received any
dextran in the postoperative period.
For us, the easiest aspect of the program to
implement has been the intraoperative TCD and
angioscopy, and we are convinced that this has con-
tributed to a significant decline in the intraoperative
stroke rate—from 4% to 0.2%. What has been more
difficult to implement is the early postoperative TCD
monitoring. In this respect, the key questions for the
future are as follows: (1) Why are certain patients
destined to have a postoperative thromboembolic
stroke despite the absence of technical error? (2)
Does this susceptibility reflect ineffective (or absent)
preoperative antiplatelet therapy? (3) Are any other
agents superior to dextran in controlling postopera-
tive embolization and progression to thrombosis?
In this series, two patients had embolic strokes
despite adjuvant dextran therapy. In one of them, we
were unable to administer an optimal dose of dextran
because of severe cardiac failure. Agents such as
Rheopro and S-Nitrosoglutathione24 may be useful
alternatives in such difficult situations, but neither
has been evaluated in large-scale studies. The other
instance of embolic stroke is the only case in our
experience in which sustained embolization recurred
some days after surgery; such a rare phenomenon
may be impossible to anticipate and prevent. Ideally,
however, it would be preferable not to have to mon-
itor any patients postoperatively. Preliminary research
in our unit suggests that the platelets of patients des-
tined to have sustained embolization have increased
sensitivity to adenosine diphosphate stimulation,25
which offers the potential for preoperative pharma-
cologic intervention and the avoidance of any post-
operative TCD monitoring in the future.
In summary, the introduction of an integrated pro-
gram of monitoring has been associated with a 60%
reduction in the 30-day risk after CEA since 1992.
The incidence of thromboembolic stroke has fallen to
less than 1%, and ICH and cardiac pathology now
account for more than 50% of all perioperative com-
plications. This sustained improvement is not simply a
reflection of increasing experience; most of the proce-
dures were performed by trainees. If anything, we are
now operating on patients at higher risk than those
whom we treated in the early 1990s, when cases of
mild and moderate stenosis were randomized in the
European Carotid Surgery Trial. However, critics
might argue that though our nonrandomized trial
results are impressive, similarly good results are achiev-
able without any monitoring or QC assessment.26
Unfortunately, large community-based studies do not
support this claim,27-30 and CEA is once again under
critical worldwide review because of concerns that the
results of the randomized trials (in which selected sur-
geons were used) may not be generalizable to routine
clinical practice. Moreover, the overall operative risk in
the North American Symptomatic Carotid Endarter-
ectomy Trial (NASCET) was 6.5%31—identical to our
own experience before we implemented the monitor-
ing and QC program. Current evidence suggests that
93% of CEAs in the United States are now performed
in non-NASCET centers with a mortality rate that is
not only higher than that reported in NASCET but
also indirectly proportional to surgeon experience and
annual workload.29,30 Data from Europe suggest a
similar trend.32 In this era of individual accountability,
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it is imperative that all surgeons quote their own
results rather than those of the international trials to
justify clinical practice. Unless steps are taken to ensure
that results with CEA are at least equal to those report-
ed in the European Carotid Surgery Trial and
NASCET, the operation could once again fall into 
disrepute.
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